First Line (1L) Pancreatic Cancer; Atebimetinib (320 mg QD) + mGnP OS, N=34

First Line (1L) Pancreatic Cancer; Atebimetinib (320 mg QD) + mGnP OS, N=34

First Line (1L) Pancreatic Cancer; Atebimetinib (320 mg QD) + mGnP OS, N=34

Format

PNG

Quelle:

Immuneering Corporation

Downloads